0001666071-20-000307.txt : 20201217
0001666071-20-000307.hdr.sgml : 20201217
20201217165849
ACCESSION NUMBER: 0001666071-20-000307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20201217
DATE AS OF CHANGE: 20201217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOMERS KIRK
CENTRAL INDEX KEY: 0001204015
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 201396770
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_160824216401396.xml
FORM 4
X0306
4
2020-12-15
0
0001666071
Cardlytics, Inc.
CDLX
0001204015
SOMERS KIRK
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
0
1
0
0
Chief Legal & Privacy Officer
Common Stock
2020-12-15
4
S
0
2169
128.81
D
79165
D
Common Stock
2020-12-15
4
S
0
5431
129.95
D
73734
D
Common Stock
2020-12-15
4
S
0
5961
130.80
D
67773
D
Common Stock
2020-12-15
4
S
0
1601
131.78
D
66172
D
Common Stock
2020-12-15
4
S
0
3000
132.85
D
63172
D
Common Stock
2020-12-15
4
S
0
203
133.70
D
62969
D
Common Stock
2020-12-15
4
S
0
2960
135
D
60009
D
Common Stock
2020-12-15
4
S
0
300
136
D
59709
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $128.30 to $129.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7), (8), (9) and (10) to this Form 4.
Includes 175 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $129.33 to $130.32, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $130.33 to $131.26, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $131.36 to $132.18, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $132.36 to $133.35, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $133.45 to $133.95, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $134.50 to $135.43, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $135.99 to $136.00, inclusive.
/s/ Kirk L. Somers
2020-12-17